Literature DB >> 19664841

Close monitoring of serum HBV DNA levels and liver enzymes levels is most useful in the management of patients with occult HBV infection.

Isabelle Chemin, Olivier Guillaud, Philippe Chevallier Queyron, Christian Trépo.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19664841     DOI: 10.1016/j.jhep.2009.06.007

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  10 in total

Review 1.  Risk of hepatitis B virus reactivation in rheumatoid arthritis patients undergoing biologic treatment: Extending perspective from old to newer drugs.

Authors:  Francesca De Nard; Monica Todoerti; Vittorio Grosso; Sara Monti; Silvia Breda; Silvia Rossi; Carlomaurizio Montecucco; Roberto Caporali
Journal:  World J Hepatol       Date:  2015-03-27

2.  Occult hepatitis B demonstrated by anti-HBc and HBV DNA in HIV-positive patients.

Authors:  Arezoo Honarmand; Morteza Pourahmad; Kavous Solhjoo; Mahmoud Kohan; Mohamad Hassan Davami; Seyed Kamyar Mostafavi Zadeh
Journal:  Rep Biochem Mol Biol       Date:  2014-10

Review 3.  Molecular mechanisms underlying occult hepatitis B virus infection.

Authors:  Jasmine Samal; Manish Kandpal; Perumal Vivekanandan
Journal:  Clin Microbiol Rev       Date:  2012-01       Impact factor: 26.132

Review 4.  Management of occult hepatitis B virus infection: an update for the clinician.

Authors:  José Luis Lledó; Conrado Fernández; María Luisa Gutiérrez; Sara Ocaña
Journal:  World J Gastroenterol       Date:  2011-03-28       Impact factor: 5.742

Review 5.  A roadmap for serum biomarkers for hepatitis B virus: current status and future outlook.

Authors:  Anna Kramvis; Kyong-Mi Chang; Maura Dandri; Patrizia Farci; Dieter Glebe; Jianming Hu; Harry L A Janssen; Daryl T Y Lau; Capucine Penicaud; Teresa Pollicino; Barbara Testoni; Florian Van Bömmel; Ourania Andrisani; Maria Beumont-Mauviel; Timothy M Block; Henry L Y Chan; Gavin A Cloherty; William E Delaney; Anna Maria Geretti; Adam Gehring; Kathy Jackson; Oliver Lenz; Mala K Maini; Veronica Miller; Ulrike Protzer; Jenny C Yang; Man-Fung Yuen; Fabien Zoulim; Peter A Revill
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2022-07-20       Impact factor: 73.082

Review 6.  Occult hepatitis B virus and hepatocellular carcinoma.

Authors:  Teresa Pollicino; Carlo Saitta
Journal:  World J Gastroenterol       Date:  2014-05-28       Impact factor: 5.742

Review 7.  Occult HBV infection.

Authors:  Giovanni Raimondo; Gaia Caccamo; Roberto Filomia; Teresa Pollicino
Journal:  Semin Immunopathol       Date:  2012-07-26       Impact factor: 9.623

Review 8.  The clinical significance of occult HBV infection.

Authors:  Giovanni Squadrito; Rosaria Spinella; Giovanni Raimondo
Journal:  Ann Gastroenterol       Date:  2014

9.  Occult HBV infection in HCC and cirrhotic tissue of HBsAg-negative patients: a virological and clinical study.

Authors:  Nicola Coppola; Lorenzo Onorato; Valentina Iodice; Mario Starace; Carmine Minichini; Nunzia Farella; Giulia Liorre; Pietro Filippini; Evangelista Sagnelli; Giorgio de Stefano
Journal:  Oncotarget       Date:  2016-09-20

Review 10.  Occult Hepatitis B Virus Infection: An Update.

Authors:  Carlo Saitta; Teresa Pollicino; Giovanni Raimondo
Journal:  Viruses       Date:  2022-07-08       Impact factor: 5.818

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.